Integration [genf]
CARDIOVASCULAR [bdsy]
Safety [hcpp]
Multifaceted [spco]
considerations [fndg]
Drug [phsu]
therapeutic use [topp]
Introduction [hlca]
CARDIOVASCULAR [bdsy]
Safety [hcpp]
Central [spco]
Component [mnob]
Drug Development [bmod]
therapeutic use [topp]
Drugs [phsu]
exert [orgf]
CARDIOVASCULAR [bdsy]
Appropriate [qlco]
Investigations [hlca]
Monitoring [hlca]
practice [menp]
Covered [ftcn]
Integration [genf]
CARDIOVASCULAR [bdsy]
Safety [hcpp]
Broad [spco]
Investigation [hlca]
Focus [spco]
Assessment [hlca]
Chosen [acty]
Advance [medd]
Challenge [clna]
Cardiotoxicity [inpo]
Oncologic [bmod]
Agent [chvf]
Target [ftcn]
blood pressure increase [fndg]
Drugs [phsu]
CARDIOVASCULAR [bdsy]
Safety [hcpp]
Antidiabetic Drugs [phsu]
Type 2 Diabetes [dsyn]
Expert Opinion [cnce]
Good [qlco]
progress [ftcn]
Make [ftcn]
In the Field [spco]
Oncology [bmod]
Last [qlco]
Decade [qnco]
Discipline [hlca]
Specific [qlco]
Training [edac]
Medical [ftcn]
Curricula [inpr]
progress [ftcn]
Make [ftcn]
Address [inpr]
Target [ftcn]
blood pressure increase [fndg]
Domain [ftcn]
Suggest [idcn]
Focus [spco]
Attention [menp]
Shift [ftcn]
CARDIOVASCULAR [bdsy]
Safety [hcpp]
CARDIOVASCULAR [bdsy]
Benefit [qnco]
Decision [menp]
FDA [hcro]
Approved [qlco]
indication [idcn]
empagliflozin [carb, phsu]
CARDIOVASCULAR [bdsy]
Adult [aggp]
Patients [podg]
Type 2 Diabetes [dsyn]
Established [qlco]
Cardiovascular disease [dsyn]
